查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球笔式註射器市场 2024-2028
市场调查报告书
商品编码
1366460

全球笔式註射器市场 2024-2028

Global Injection Pen Market 2024-2028
出版日期: | 出版商: TechNavio | 英文 172 Pages | 订单完成后即时交付

价格

笔式註射器市场预计在 2023 年至 2028 年期间将成长 255.1 亿美元，预测期内年复合成长率为 8.13%。

该报告包括对笔式註射器市场的总体分析、市场规模和预测、趋势、成长动力、挑战以及涵盖约 25 家供应商的供应商分析。

该报告提供了对当前市场状况、最新趋势和驱动因素以及整体市场环境的最新分析。慢性病盛行率的上升、糖尿病患者数量的增加以及注射疗法的日益普及正在推动市场的发展。

市场范围
基准年 2022年
结束年份 2027年
预测期 2023-2027
成长动力 加速度
与前一年同期比较 7.54%
年复合成长率 8.13%
增量 255.1亿美元

报告指出，胰岛素笔需求的大幅成长是未来年度推动笔式註射器市场成长的关键因素之一。此外，供应商越来越多地推出笔式註射器产品以及不断增加新产品的商业批准，导致市场需求强劲。

目录

第1章执行摘要

  • 市场概况

第2章市场形势

  • 市场生态系统

第3章市场规模

  • 市场定义
  • 细分市场分析
  • 2023 年市场规模
  • 2023-2028年市场展望

第4章市场规模实绩

  • 2018-2022 年全球笔式註射器市场
  • 2018-2022 年按产品細項分析
  • 2018-2022 年按类型分類的细分市场分析
  • 2018-2022 年区域細項分析
  • 2018-2022 年国家細項分析

第5章五力分析

  • 五力摘要
  • 买方议价能力
  • 供应商的议价能力
  • 新进入者的威胁
  • 替代的威胁
  • 竞争威胁
  • 市场状况

第6章市场区隔：依产品

  • 细分市场
  • 比较：按产品
  • 生长激素：2023-2028年市场规模及预测
  • 糖尿病：2023-2028 年市场规模与预测
  • 生育力：2023-2028 年市场规模与预测
  • 骨质疏鬆症：2023-2028 年市场规模与预测
  • 其他：2023-2028年市场规模与预测
  • 市场机会：依产品分类

第7章市场区隔：依类型

  • 细分市场
  • 比较：按类型
  • 一次性笔式註射器：2023-2028 年市场规模与预测
  • 可重复使用笔式註射器：2023-2028 年市场规模与预测
  • 市场机会：按类型

第8章客户形势

  • 客户形势概览

第9章地区形势

  • 区域细分
  • 区域比较
  • 北美：2023-2028 年市场规模与预测
  • 欧洲：2023-2028 年市场规模与预测
  • 亚洲：2023-2028年市场规模与预测
  • 世界其他地区：2023-2028 年市场规模与预测
  • 美国：2023-2028 年市场规模与预测
  • 中国：2023-2028年市场规模及预测
  • 加拿大：2023-2028 年市场规模与预测
  • 德国：2023-2028 年市场规模与预测
  • 英国：2023-2028 年市场规模与预测
  • 市场机会：按地区

第10章推动因素、问题与趋势

  • 市场驱动因素
  • 市场挑战
  • 驱动因素和挑战的影响
  • 市场趋势

第11章供应商形势

  • 概述
  • 供应商形势
  • 混乱的情况
  • 产业风险

第12章供应商分析

  • 交易厂商
  • 供应商市场定位
  • AstraZeneca Plc
  • Becton Dickinson and Co.
  • Biocon Ltd.
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • Gerresheimer AG
  • GlaxoSmithKline Plc
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk AS
  • Owen Mumford Ltd.
  • Pfizer Inc.
  • Sanofi
  • Viatris Inc.
  • Ypsomed Holding AG

第13章附录

Product Code: IRTNTR71195

The injection pen market is forecasted to grow by USD 25.51 bn during 2023-2028, accelerating at a CAGR of 8.13% during the forecast period. The report on the injection pen market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of chronic diseases, the growing prevalence of diabetes cases, and the growing popularity of injectable therapies.

Technavio's injection pen market is segmented as below:

Market Scope
Base Year2022
End Year2027
Series Year2023-2027
Growth MomentumAccelerate
YOY 20237.54%
CAGR8.13%
Incremental Value$25.51bn

By Product

  • Growth hormone
  • Diabetes
  • Fertility
  • Osteoporosis
  • Others

By Type

  • Disposable injection pen
  • Reusable injection pen

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the significant rise in demand for insulin pens as one of the prime reasons driving the injection pen market growth during the next few years. Also, increasing injection pen product launches by market vendors and rise in commercial approvals of new products will lead to sizable demand in the market.

The report on the injection pen market covers the following areas:

  • Injection pen market sizing
  • Injection pen market forecast
  • Injection pen market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading injection pen market vendors that include AstraZeneca Plc, Becton Dickinson and Co., Biocon Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gan and Lee Pharmaceuticals Co. Ltd., Gerresheimer AG, GlaxoSmithKline Plc, Harro Hofliger GmbH, Haselmeier GmbH, Jiangsu Delfu medical device Co. Ltd., Merck KGaA, Novartis AG, Novo Nordisk AS, Owen Mumford Ltd., Pfizer Inc., Sanofi, Solteam Electronics Co LTD., Viatris Inc., and Ypsomed Holding AG. Also, the injection pen market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
  • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global injection pen market 2018 - 2022
  • Exhibit 18: Historic Market Size - Data Table on global injection pen market 2018 - 2022 ($ billion)
  • 4.2 Product Segment Analysis 2018 - 2022
  • Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
  • 4.3 Type Segment Analysis 2018 - 2022
  • Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
  • 4.4 Geography Segment Analysis 2018 - 2022
  • Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • 4.5 Country Segment Analysis 2018 - 2022
  • Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

  • 6.1 Market segments
  • Exhibit 30: Chart on Product - Market share 2023-2028 (%)
  • Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
  • 6.2 Comparison by Product
  • Exhibit 32: Chart on Comparison by Product
  • Exhibit 33: Data Table on Comparison by Product
  • 6.3 Growth hormone - Market size and forecast 2023-2028
  • Exhibit 34: Chart on Growth hormone - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 35: Data Table on Growth hormone - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 36: Chart on Growth hormone - Year-over-year growth 2023-2028 (%)
  • Exhibit 37: Data Table on Growth hormone - Year-over-year growth 2023-2028 (%)
  • 6.4 Diabetes - Market size and forecast 2023-2028
  • Exhibit 38: Chart on Diabetes - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 39: Data Table on Diabetes - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 40: Chart on Diabetes - Year-over-year growth 2023-2028 (%)
  • Exhibit 41: Data Table on Diabetes - Year-over-year growth 2023-2028 (%)
  • 6.5 Fertility - Market size and forecast 2023-2028
  • Exhibit 42: Chart on Fertility - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 43: Data Table on Fertility - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 44: Chart on Fertility - Year-over-year growth 2023-2028 (%)
  • Exhibit 45: Data Table on Fertility - Year-over-year growth 2023-2028 (%)
  • 6.6 Osteoporosis - Market size and forecast 2023-2028
  • Exhibit 46: Chart on Osteoporosis - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 47: Data Table on Osteoporosis - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 48: Chart on Osteoporosis - Year-over-year growth 2023-2028 (%)
  • Exhibit 49: Data Table on Osteoporosis - Year-over-year growth 2023-2028 (%)
  • 6.7 Others - Market size and forecast 2023-2028
  • Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • 6.8 Market opportunity by Product
  • Exhibit 54: Market opportunity by Product ($ billion)
  • Exhibit 55: Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by Type

  • 7.1 Market segments
  • Exhibit 56: Chart on Type - Market share 2023-2028 (%)
  • Exhibit 57: Data Table on Type - Market share 2023-2028 (%)
  • 7.2 Comparison by Type
  • Exhibit 58: Chart on Comparison by Type
  • Exhibit 59: Data Table on Comparison by Type
  • 7.3 Disposable injection pen - Market size and forecast 2023-2028
  • Exhibit 60: Chart on Disposable injection pen - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 61: Data Table on Disposable injection pen - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 62: Chart on Disposable injection pen - Year-over-year growth 2023-2028 (%)
  • Exhibit 63: Data Table on Disposable injection pen - Year-over-year growth 2023-2028 (%)
  • 7.4 Reusable injection pen - Market size and forecast 2023-2028
  • Exhibit 64: Chart on Reusable injection pen - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 65: Data Table on Reusable injection pen - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 66: Chart on Reusable injection pen - Year-over-year growth 2023-2028 (%)
  • Exhibit 67: Data Table on Reusable injection pen - Year-over-year growth 2023-2028 (%)
  • 7.5 Market opportunity by Type
  • Exhibit 68: Market opportunity by Type ($ billion)
  • Exhibit 69: Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
  • Exhibit 73: Chart on Geographic comparison
  • Exhibit 74: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
  • Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
  • Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
  • Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
  • Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 China - Market size and forecast 2023-2028
  • Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.9 Canada - Market size and forecast 2023-2028
  • Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 9.10 Germany - Market size and forecast 2023-2028
  • Exhibit 103: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 104: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 105: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibit 106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.11 UK - Market size and forecast 2023-2028
  • Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
  • Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 113: Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 115: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 116: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 117: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 118: Matrix on vendor position and classification
  • 12.3 AstraZeneca Plc
  • Exhibit 119: AstraZeneca Plc - Overview
  • Exhibit 120: AstraZeneca Plc - Product / Service
  • Exhibit 121: AstraZeneca Plc - Key news
  • Exhibit 122: AstraZeneca Plc - Key offerings
  • 12.4 Becton Dickinson and Co.
  • Exhibit 123: Becton Dickinson and Co. - Overview
  • Exhibit 124: Becton Dickinson and Co. - Business segments
  • Exhibit 125: Becton Dickinson and Co. - Key news
  • Exhibit 126: Becton Dickinson and Co. - Key offerings
  • Exhibit 127: Becton Dickinson and Co. - Segment focus
  • 12.5 Biocon Ltd.
  • Exhibit 128: Biocon Ltd. - Overview
  • Exhibit 129: Biocon Ltd. - Business segments
  • Exhibit 130: Biocon Ltd. - Key offerings
  • Exhibit 131: Biocon Ltd. - Segment focus
  • 12.6 Eli Lilly and Co.
  • Exhibit 132: Eli Lilly and Co. - Overview
  • Exhibit 133: Eli Lilly and Co. - Product / Service
  • Exhibit 134: Eli Lilly and Co. - Key news
  • Exhibit 135: Eli Lilly and Co. - Key offerings
  • 12.7 F. Hoffmann La Roche Ltd.
  • Exhibit 136: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 137: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 138: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 139: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 140: F. Hoffmann La Roche Ltd. - Segment focus
  • 12.8 Gerresheimer AG
  • Exhibit 141: Gerresheimer AG - Overview
  • Exhibit 142: Gerresheimer AG - Business segments
  • Exhibit 143: Gerresheimer AG - Key news
  • Exhibit 144: Gerresheimer AG - Key offerings
  • Exhibit 145: Gerresheimer AG - Segment focus
  • 12.9 GlaxoSmithKline Plc
  • Exhibit 146: GlaxoSmithKline Plc - Overview
  • Exhibit 147: GlaxoSmithKline Plc - Business segments
  • Exhibit 148: GlaxoSmithKline Plc - Key news
  • Exhibit 149: GlaxoSmithKline Plc - Key offerings
  • Exhibit 150: GlaxoSmithKline Plc - Segment focus
  • 12.10 Merck KGaA
  • Exhibit 151: Merck KGaA - Overview
  • Exhibit 152: Merck KGaA - Business segments
  • Exhibit 153: Merck KGaA - Key news
  • Exhibit 154: Merck KGaA - Key offerings
  • Exhibit 155: Merck KGaA - Segment focus
  • 12.11 Novartis AG
  • Exhibit 156: Novartis AG - Overview
  • Exhibit 157: Novartis AG - Business segments
  • Exhibit 158: Novartis AG - Key offerings
  • Exhibit 159: Novartis AG - Segment focus
  • 12.12 Novo Nordisk AS
  • Exhibit 160: Novo Nordisk AS - Overview
  • Exhibit 161: Novo Nordisk AS - Business segments
  • Exhibit 162: Novo Nordisk AS - Key offerings
  • Exhibit 163: Novo Nordisk AS - Segment focus
  • 12.13 Owen Mumford Ltd.
  • Exhibit 164: Owen Mumford Ltd. - Overview
  • Exhibit 165: Owen Mumford Ltd. - Product / Service
  • Exhibit 166: Owen Mumford Ltd. - Key offerings
  • 12.14 Pfizer Inc.
  • Exhibit 167: Pfizer Inc. - Overview
  • Exhibit 168: Pfizer Inc. - Product / Service
  • Exhibit 169: Pfizer Inc. - Key news
  • Exhibit 170: Pfizer Inc. - Key offerings
  • 12.15 Sanofi
  • Exhibit 171: Sanofi - Overview
  • Exhibit 172: Sanofi - Business segments
  • Exhibit 173: Sanofi - Key news
  • Exhibit 174: Sanofi - Key offerings
  • Exhibit 175: Sanofi - Segment focus
  • 12.16 Viatris Inc.
  • Exhibit 176: Viatris Inc. - Overview
  • Exhibit 177: Viatris Inc. - Business segments
  • Exhibit 178: Viatris Inc. - Key news
  • Exhibit 179: Viatris Inc. - Key offerings
  • Exhibit 180: Viatris Inc. - Segment focus
  • 12.17 Ypsomed Holding AG
  • Exhibit 181: Ypsomed Holding AG - Overview
  • Exhibit 182: Ypsomed Holding AG - Business segments
  • Exhibit 183: Ypsomed Holding AG - Key offerings
  • Exhibit 184: Ypsomed Holding AG - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 185: Inclusions checklist
  • Exhibit 186: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 187: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 188: Research methodology
  • Exhibit 189: Validation techniques employed for market sizing
  • Exhibit 190: Information sources
  • 13.5 List of abbreviations
  • Exhibit 191: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits18: Historic Market Size - Data Table on global injection pen market 2018 - 2022 ($ billion)
  • Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
  • Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
  • Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
  • Exhibits23: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits29: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits30: Chart on Product - Market share 2023-2028 (%)
  • Exhibits31: Data Table on Product - Market share 2023-2028 (%)
  • Exhibits32: Chart on Comparison by Product
  • Exhibits33: Data Table on Comparison by Product
  • Exhibits34: Chart on Growth hormone - Market size and forecast 2023-2028 ($ billion)
  • Exhibits35: Data Table on Growth hormone - Market size and forecast 2023-2028 ($ billion)
  • Exhibits36: Chart on Growth hormone - Year-over-year growth 2023-2028 (%)
  • Exhibits37: Data Table on Growth hormone - Year-over-year growth 2023-2028 (%)
  • Exhibits38: Chart on Diabetes - Market size and forecast 2023-2028 ($ billion)
  • Exhibits39: Data Table on Diabetes - Market size and forecast 2023-2028 ($ billion)
  • Exhibits40: Chart on Diabetes - Year-over-year growth 2023-2028 (%)
  • Exhibits41: Data Table on Diabetes - Year-over-year growth 2023-2028 (%)
  • Exhibits42: Chart on Fertility - Market size and forecast 2023-2028 ($ billion)
  • Exhibits43: Data Table on Fertility - Market size and forecast 2023-2028 ($ billion)
  • Exhibits44: Chart on Fertility - Year-over-year growth 2023-2028 (%)
  • Exhibits45: Data Table on Fertility - Year-over-year growth 2023-2028 (%)
  • Exhibits46: Chart on Osteoporosis - Market size and forecast 2023-2028 ($ billion)
  • Exhibits47: Data Table on Osteoporosis - Market size and forecast 2023-2028 ($ billion)
  • Exhibits48: Chart on Osteoporosis - Year-over-year growth 2023-2028 (%)
  • Exhibits49: Data Table on Osteoporosis - Year-over-year growth 2023-2028 (%)
  • Exhibits50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
  • Exhibits51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
  • Exhibits52: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits53: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits54: Market opportunity by Product ($ billion)
  • Exhibits55: Data Table on Market opportunity by Product ($ billion)
  • Exhibits56: Chart on Type - Market share 2023-2028 (%)
  • Exhibits57: Data Table on Type - Market share 2023-2028 (%)
  • Exhibits58: Chart on Comparison by Type
  • Exhibits59: Data Table on Comparison by Type
  • Exhibits60: Chart on Disposable injection pen - Market size and forecast 2023-2028 ($ billion)
  • Exhibits61: Data Table on Disposable injection pen - Market size and forecast 2023-2028 ($ billion)
  • Exhibits62: Chart on Disposable injection pen - Year-over-year growth 2023-2028 (%)
  • Exhibits63: Data Table on Disposable injection pen - Year-over-year growth 2023-2028 (%)
  • Exhibits64: Chart on Reusable injection pen - Market size and forecast 2023-2028 ($ billion)
  • Exhibits65: Data Table on Reusable injection pen - Market size and forecast 2023-2028 ($ billion)
  • Exhibits66: Chart on Reusable injection pen - Year-over-year growth 2023-2028 (%)
  • Exhibits67: Data Table on Reusable injection pen - Year-over-year growth 2023-2028 (%)
  • Exhibits68: Market opportunity by Type ($ billion)
  • Exhibits69: Data Table on Market opportunity by Type ($ billion)
  • Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits73: Chart on Geographic comparison
  • Exhibits74: Data Table on Geographic comparison
  • Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits103: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits104: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits105: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibits108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibits109: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits110: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits111: Market opportunity By Geographical Landscape ($ billion)
  • Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
  • Exhibits113: Impact of drivers and challenges in 2023 and 2028
  • Exhibits114: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits115: Overview on factors of disruption
  • Exhibits116: Impact of key risks on business
  • Exhibits117: Vendors covered
  • Exhibits118: Matrix on vendor position and classification
  • Exhibits119: AstraZeneca Plc - Overview
  • Exhibits120: AstraZeneca Plc - Product / Service
  • Exhibits121: AstraZeneca Plc - Key news
  • Exhibits122: AstraZeneca Plc - Key offerings
  • Exhibits123: Becton Dickinson and Co. - Overview
  • Exhibits124: Becton Dickinson and Co. - Business segments
  • Exhibits125: Becton Dickinson and Co. - Key news
  • Exhibits126: Becton Dickinson and Co. - Key offerings
  • Exhibits127: Becton Dickinson and Co. - Segment focus
  • Exhibits128: Biocon Ltd. - Overview
  • Exhibits129: Biocon Ltd. - Business segments
  • Exhibits130: Biocon Ltd. - Key offerings
  • Exhibits131: Biocon Ltd. - Segment focus
  • Exhibits132: Eli Lilly and Co. - Overview
  • Exhibits133: Eli Lilly and Co. - Product / Service
  • Exhibits134: Eli Lilly and Co. - Key news
  • Exhibits135: Eli Lilly and Co. - Key offerings
  • Exhibits136: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits137: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits138: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits139: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits140: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits141: Gerresheimer AG - Overview
  • Exhibits142: Gerresheimer AG - Business segments
  • Exhibits143: Gerresheimer AG - Key news
  • Exhibits144: Gerresheimer AG - Key offerings
  • Exhibits145: Gerresheimer AG - Segment focus
  • Exhibits146: GlaxoSmithKline Plc - Overview
  • Exhibits147: GlaxoSmithKline Plc - Business segments
  • Exhibits148: GlaxoSmithKline Plc - Key news
  • Exhibits149: GlaxoSmithKline Plc - Key offerings
  • Exhibits150: GlaxoSmithKline Plc - Segment focus
  • Exhibits151: Merck KGaA - Overview
  • Exhibits152: Merck KGaA - Business segments
  • Exhibits153: Merck KGaA - Key news
  • Exhibits154: Merck KGaA - Key offerings
  • Exhibits155: Merck KGaA - Segment focus
  • Exhibits156: Novartis AG - Overview
  • Exhibits157: Novartis AG - Business segments
  • Exhibits158: Novartis AG - Key offerings
  • Exhibits159: Novartis AG - Segment focus
  • Exhibits160: Novo Nordisk AS - Overview
  • Exhibits161: Novo Nordisk AS - Business segments
  • Exhibits162: Novo Nordisk AS - Key offerings
  • Exhibits163: Novo Nordisk AS - Segment focus
  • Exhibits164: Owen Mumford Ltd. - Overview
  • Exhibits165: Owen Mumford Ltd. - Product / Service
  • Exhibits166: Owen Mumford Ltd. - Key offerings
  • Exhibits167: Pfizer Inc. - Overview
  • Exhibits168: Pfizer Inc. - Product / Service
  • Exhibits169: Pfizer Inc. - Key news
  • Exhibits170: Pfizer Inc. - Key offerings
  • Exhibits171: Sanofi - Overview
  • Exhibits172: Sanofi - Business segments
  • Exhibits173: Sanofi - Key news
  • Exhibits174: Sanofi - Key offerings
  • Exhibits175: Sanofi - Segment focus
  • Exhibits176: Viatris Inc. - Overview
  • Exhibits177: Viatris Inc. - Business segments
  • Exhibits178: Viatris Inc. - Key news
  • Exhibits179: Viatris Inc. - Key offerings
  • Exhibits180: Viatris Inc. - Segment focus
  • Exhibits181: Ypsomed Holding AG - Overview
  • Exhibits182: Ypsomed Holding AG - Business segments
  • Exhibits183: Ypsomed Holding AG - Key offerings
  • Exhibits184: Ypsomed Holding AG - Segment focus
  • Exhibits185: Inclusions checklist
  • Exhibits186: Exclusions checklist
  • Exhibits187: Currency conversion rates for US$
  • Exhibits188: Research methodology
  • Exhibits189: Validation techniques employed for market sizing
  • Exhibits190: Information sources
  • Exhibits191: List of abbreviations